JAGLX vs. JNGLX
JAGLX (Janus Henderson Global Life Sciences Fund Class T) and JNGLX (Janus Henderson Global Life Sciences Fund) are both Health & Biotech Equities funds from Janus Henderson. Over the past 10 years, JAGLX returned 10.94%/yr vs 10.41%/yr for JNGLX. With a 1.00 correlation, they move nearly in lockstep. JAGLX charges 0.92%/yr vs 0.80%/yr for JNGLX.
Performance
JAGLX vs. JNGLX - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with JAGLX having a -2.55% return and JNGLX slightly higher at -2.51%. Both investments have delivered pretty close results over the past 10 years, with JAGLX having a 10.94% annualized return and JNGLX not far behind at 10.41%.
JAGLX
- 1D
- 1.14%
- 1M
- -0.31%
- YTD
- -2.55%
- 6M
- -0.80%
- 1Y
- 26.04%
- 3Y*
- 11.36%
- 5Y*
- 8.05%
- 10Y*
- 10.94%
JNGLX
- 1D
- 1.13%
- 1M
- -0.29%
- YTD
- -2.51%
- 6M
- -0.73%
- 1Y
- 26.17%
- 3Y*
- 9.73%
- 5Y*
- 7.15%
- 10Y*
- 10.41%
JAGLX vs. JNGLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | -2.55% | 24.72% | 8.50% | 7.41% | -2.79% | 6.66% | 25.52% | 29.12% | 4.05% | 22.13% |
JNGLX Janus Henderson Global Life Sciences Fund | -2.51% | 24.84% | 3.60% | 7.51% | -2.69% | 6.78% | 25.66% | 29.20% | 4.17% | 22.13% |
Correlation
The correlation between JAGLX and JNGLX is 1.00 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 1.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.99 |
Correlation (5Y) Calculated over the trailing 5-year period | 1.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 1.00 |
Correlation (All Time) Calculated using the full available price history since Jan 5, 1999 | 1.00 |
The correlation between JAGLX and JNGLX has been stable across timeframes, ranging from 0.99 to 1.00 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JAGLX vs. JNGLX — Risk / Return Rank
JAGLX
JNGLX
JAGLX vs. JNGLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class T (JAGLX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JAGLX | JNGLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.01 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.31 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 2.73 | 2.75 | -0.02 |
| Martin ratioReturn relative to average drawdown | 8.66 | 8.75 | -0.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| JAGLX | JNGLX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.78 | 1.79 | -0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.45 | +0.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.63 | 0.60 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.57 | +0.01 |
Drawdowns
JAGLX vs. JNGLX - Drawdown Comparison
The maximum JAGLX drawdown since its inception was -58.96%, roughly equal to the maximum JNGLX drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for JAGLX and JNGLX.
Loading charts...
Drawdown Indicators
| JAGLX | JNGLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.96% | -59.00% | +0.04% |
Max Drawdown (1Y)Largest decline over 1 year | -9.71% | -9.68% | -0.03% |
Max Drawdown (3Y)Largest decline over 3 years | -17.41% | -21.17% | +3.76% |
Max Drawdown (5Y)Largest decline over 5 years | -22.25% | -22.21% | -0.04% |
Max Drawdown (10Y)Largest decline over 10 years | -27.38% | -27.37% | -0.01% |
Current DrawdownCurrent decline from peak | -5.47% | -5.44% | -0.03% |
Average DrawdownAverage peak-to-trough decline | -17.43% | -17.65% | +0.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.05% | 3.04% | +0.01% |
Volatility
JAGLX vs. JNGLX - Volatility Comparison
Janus Henderson Global Life Sciences Fund Class T (JAGLX) and Janus Henderson Global Life Sciences Fund (JNGLX) have volatilities of 4.81% and 4.80%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JAGLX | JNGLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.81% | 4.80% | +0.01% |
Volatility (6M)Calculated over the trailing 6-month period | 10.89% | 10.89% | 0.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.86% | 14.86% | 0.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.92% | 15.86% | +0.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.41% | 17.38% | +0.03% |
JAGLX vs. JNGLX - Expense Ratio Comparison
JAGLX has a 0.92% expense ratio, which is higher than JNGLX's 0.80% expense ratio.
Dividends
JAGLX vs. JNGLX - Dividend Comparison
JAGLX's dividend yield for the trailing twelve months is around 4.65%, which matches JNGLX's 4.68% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | 4.65% | 4.53% | 10.98% | 4.22% | 0.14% | 9.78% | 7.75% | 6.17% | 13.38% | 0.89% | 1.13% | 9.09% |
JNGLX Janus Henderson Global Life Sciences Fund | 4.68% | 4.56% | 5.84% | 4.26% | 0.25% | 9.85% | 7.80% | 6.23% | 13.32% | 0.89% | 0.30% | 8.81% |
Frequently Asked Questions
With a correlation of 1.00, JAGLX and JNGLX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
JAGLX has higher volatility (4.81%) compared to JNGLX (4.80%). In terms of maximum drawdown, JAGLX dropped -58.96% vs JNGLX's -59.00%.
JNGLX currently has the higher Sharpe Ratio (1.79 vs 1.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JAGLX and JNGLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer